Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.
about
Development of venetoclax for therapy of lymphoid malignancies.Rational combination strategies to enhance venetoclax activity and overcome resistance in hematologic malignancies.BCL2/Ki-67 index predict survival in germinal center B-cell-like diffuse large B-cell lymphoma.Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma
P2860
Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.
@ast
Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.
@en
type
label
Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.
@ast
Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.
@en
prefLabel
Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.
@ast
Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.
@en
P2093
P2860
P356
P1433
P1476
Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199
@en
P2093
Arnau Montraveta
Clara Campàs
Dolors Colomer
Elias Campo
Eriong Lee-Vergés
Jocabed Roldán
Laia Rosich
Mercè de Frías
Mònica López-Guerra
Vanina Rodríguez
P2860
P304
21159-21172
P356
10.18632/ONCOTARGET.4230
P407
P577
2015-08-01T00:00:00Z